Amyloid beta-peptide1-42 alters tight junction protein distribution and expression in brain microvessel endothelial cells

Neuroscience Letters
Sonia Marco, Stephen D Skaper

Abstract

Alzheimer's disease is characterised by neuronal loss, numerous intraneuronal deposits of neurofibrillary tangles, senile plaques, and cerebrovascular amyloid deposits. The major component of senile plaques and cerebrovascular deposits is the 39-43 amino acid beta-amyloid peptide (Abeta). The effects of Abeta on cerebral endothelium and thus the blood-brain barrier remain unclear. Utilising endothelial cells isolated from rat cerebral cortex microvessels, we have examined effects of Abeta peptides on tight junction protein behaviour. The transmembrane tight junction proteins occludin, claudin-1 and claudin-5, as well as the cytoplasmic accessory proteins ZO-1 and ZO-2 displayed a continuous distribution at cell boundaries. Endothelial cells exposed to Abeta1-42 (20 microM) for 3 days showed a disrupted plasma membrane pattern of claudin-5 and ZO-2 with relocation to the cytoplasm. These effects were not seen with Abeta25-35 or Abeta1-40[Gln22] (Dutch type). Abeta1-42 treatment altered also protein expression: occludin was lower at 1st day, claudin-1 increased at all times, and ZO-2 increased after 1 day and then decreased. These data suggest that Abeta1-42 effects on tight junction protein complexes may alter blood-brain barrie...Continue Reading

References

Dec 1, 1993·The Journal of Cell Biology·M FuruseS Tsukita
Sep 1, 1996·Journal of Pharmacological and Toxicological Methods·N IchikawaK Iwamoto
Jan 20, 1999·Proceedings of the National Academy of Sciences of the United States of America·K MoritaS Tsukita
Jun 17, 1999·Trends in Cell Biology·S Tsukita, M Furuse
Oct 6, 1999·Current Opinion in Cell Biology·S TsukitaM Itoh
Feb 26, 2000·Cellular and Molecular Neurobiology·H C Bauer, H Bauer
Feb 26, 2000·Cellular and Molecular Neurobiology·U Kniesel, H Wolburg
Jun 20, 2000·Neurobiology of Aging·H AkiyamaT Wyss-Coray
Aug 10, 2000·Neuropathology : Official Journal of the Japanese Society of Neuropathology·M Yamada
Mar 29, 2001·Physiological Reviews·D J Selkoe
Aug 8, 2001·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·J XuC Y Hsu
Mar 15, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Karen S Mark, Thomas P Davis
Aug 15, 2002·American Journal of Physiology. Cell Physiology·Ranjit GiriVijay K Kalra
Jan 18, 2003·Vascular Pharmacology·Hartwig Wolburg, Andrea Lippoldt
Jan 18, 2003·Progress in Neurobiology·Margaret A Petty, Eng H Lo
Feb 4, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Mark WogulisRussell E Rydel

❮ Previous
Next ❯

Citations

May 4, 2010·Molecular Neurobiology·Xiaoguang YangJames C-M Lee
Sep 17, 2013·Biosensors & Bioelectronics·Mihaela GheorghiuEugen Gheorghiu
Jan 18, 2011·Antioxidants & Redox Signaling·Ingolf E BlasigReiner F Haseloff
Feb 8, 2011·Antioxidants & Redox Signaling·Anna CarranoHelga E de Vries
Jan 16, 2010·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Noboru Toda, Kazuhide Ayajiki
Oct 1, 2010·Therapeutic Delivery·Joseph A Nicolazzo, Dharmini C Mehta
Feb 11, 2014·Cell Metabolism·Sophie StukasCheryl L Wellington
Jun 21, 2011·Cardiovascular Psychiatry and Neurology·Valerie C AndersonWilliam D Rooney
Sep 22, 2009·Canadian Journal of Physiology and Pharmacology·Noboru TodaTomio Okamura
Nov 8, 2012·Journal of Neuroscience Methods·Diane M WuestKelvin H Lee
Apr 2, 2008·Journal of Neuropathology and Experimental Neurology·John E Donahue, Conrad E Johanson
Dec 30, 2015·Acta Neuropathologica·Seth Love, J Scott Miners
Mar 15, 2016·Frontiers in Microbiology·Bruno M Di Genova, Renata R Tonelli
Apr 7, 2010·Journal of Biomedicine & Biotechnology·Teo VargasEva Carro
May 11, 2015·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Róisín M McManusMarina A Lynch
Jul 20, 2007·Journal of Cellular and Molecular Medicine·Mihaela Oana RomanitanNenad Bogdanovic
Mar 26, 2016·Frontiers in Pharmacology·T Michael De Silva, Alyson A Miller
Feb 13, 2014·Journal of Neurochemistry·Diane M Wuest, Kelvin H Lee
Jun 16, 2015·Frontiers in Neuroscience·Donghui ZhuSholpan Askarova
Aug 21, 2013·Journal of Pharmaceutical and Biomedical Analysis·Dharmini C MehtaJoseph A Nicolazzo
Mar 26, 2014·Tissue Barriers·Andreia GonçalvesRosa Fernandes
Oct 17, 2014·Pharmaceutical Research·Dharmini C MehtaJoseph A Nicolazzo
Mar 8, 2008·Neurobiology of Aging·Adam S FleisherRichard B Buxton
Dec 9, 2008·Neurobiology of Aging·Susan A Austin, Colin K Combs
Nov 30, 2016·Vascular Pharmacology·A ChakrabortyH E de Vries
May 11, 2017·Journal of Neurochemistry·Simona Federica SpampinatoMaria Angela Sortino
Sep 14, 2017·International Journal of Molecular Sciences·Yu Yamazaki, Takahisa Kanekiyo
Feb 4, 2012·Neuro-degenerative Diseases·Anna CarranoAnnemieke J M Rozemuller
Feb 26, 2009·Free Radical Research·Pamela B L PunShabbir Moochhala
Dec 2, 2011·Médecine sciences : M/S·Fabien GosseletLaurence Fenart
Mar 21, 2020·Integrative Biology : Quantitative Biosciences From Nano to Macro·Blakely B O'ConnorKevin Kit Parker
Feb 26, 2009·Aging Cell·Julien BrubanFrédéric Mascarelli
May 15, 2019·Journal of Clinical Medicine·Karan GovindpaniAndrea Kwakowsky
Nov 7, 2019·International Journal of Molecular Sciences·Laura CosteaIstván A Krizbai
Mar 9, 2013·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Noboru Toda
Dec 31, 2019·Journal of Alzheimer's Disease : JAD·Miao SunHui Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.